Skip to main content

Table 5 Surgical results

From: Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy

 

Neoadjuvant ( n= 80)

Adjuvant ( n= 90)

P a

Total operative time

230.4

212.2

0.017

Operative blood loss (mL)

300

200

0.050

  ≥ 200

66 (83.5%)

60 (66.7%)

0.014

Procedure

0.320b

  Total gastrectomy

23 (28.8%)

30 (33.3%)

0.249c

  Roux-en-Y

23 (100.0%)

27 (90.0%)

 

  Braun

0 (0%)

3 (10.0%)

 

  Distal gastrectomy

33 (41.2%)

42 (46.7%)

0.425d

  Billroth I

26 (78.8%)

28 (66.7%)

 

  Billroth II

2 (6.1%)

6 (14.3%)

 

  Roux-en-Y

5 (15.1%)

8 (19.0%)

 

  Proximal gastrectomy

24 (30.0%)

18 (20.0%)

  Esophagogastric anastomosis

24 (100.0%)

18 (100.0%)

 

Extent of resection

0.872

  R0

76 (95.0%)

85 (94.4%)

 

  R1/R2

4 (5.0%)

5 (5.6%)

 

Mean no. of nodes removed

29

30

0.317

  1. aChi-square test; bcomparison of total, distal, and proximal gastrectomies; ccomparison of Roux-en-Y and Braun; dcomparison of Billroth I, Billroth II, and Roux-en-Y.